Skip to main content

Academic Integration efforts lead to $33M in grants

Seed grants and symposia based on themes from the Office of Academic Integration have bridged researchers from the Ithaca and New York campuses and have brought a high return on investment to Cornell. 

Weill Cornell awarded $28.5M grant to lead HIV cure research

The grant will fund a Weill Cornell Medicine-based program known as REACH: Research Enterprise to Advance a Cure for HIV, which was formed in late 2020.

First-year medical students don white coats in historic year

Members of the Weill Cornell Medical College Class of 2025 received their white coats Aug. 20, kicking off their medical educations.    

Planes four times as likely to hit birds during migrations

The risk of airplanes colliding with birds increases greatly during migrations, according to research from the Cornell Lab of Ornithology and partners, who have been looking for patterns in data from three New York City-area airports.

Hackers can ‘poison’ open-source code on the internet

New Cornell Tech research shows how new blind attacks could compromise everything from email accounts to algorithmic trading.

NYC summer shapes Milstein students’ thoughts about future

Sophomore students in the Milstein Program in Technology and Humanity spent their first summer in person at Cornell Tech, taking part in a series of mentored workshops, guest seminars, group projects, innovation challenges and other activities.

Dr. Geraldine McGinty appointed senior associate dean for clinical affairs

Dr. Geraldine McGinty, an esteemed clinical operations strategist, administrator and radiologist, has been appointed senior associate dean for clinical affairs at Weill Cornell Medicine, effective Sept. 1.

Around Cornell

Cancer vaccine improves outcomes in Lynch syndrome model

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.

Treatment with endothelial cells reverses emphysema in model

The specialized endothelial cells that line the blood vessels in the lung may hold the key to treating the common and often-fatal lung disease emphysema, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.